SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as traders react to Larry Ellison's surprise cancellation of his plan to sell up to 50 million shares, which the community widely interprets as a bullish catalyst to trap short sellers. While some investors argue that persistent concerns over high capital expenditures and debt levels continue to weigh on the stock, many are anticipating a potential short squeeze on Monday.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is discussing the rapid and substantial price collapse of the recently launched meme coin, with many traders labeling the event a "rug pull" and highlighting significant financial losses. Opinions remain highly polarized, with some participants expressing intense skepticism toward the project's legitimacy while others debate the broader implications of meme coin volatility.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Traders are actively debating the impact of rising oil prices, bond yields, and ongoing geopolitical tensions in the Middle East on gold as a potential hedge against currency debasement and sovereign debt concerns. Discussion is divided between those monitoring these macroeconomic pressures for a gold rally and others noting the volatility of precious metals in the current market environment.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as traders focus on the upcoming November PDUFA date for ivonescimab and continued confidence in the company's oncology pipeline. While some market participants express concerns regarding ongoing financing needs and regulatory risks, the conversation remains largely bullish, heavily influenced by significant recent insider purchases and the potential for ivonescimab to challenge existing standard-of-care treatments.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The primary catalyst for the conversation is the heightened expectation of a Federal Reserve interest rate hike in September, driven by stronger-than-expected jobs data and persistent inflationary pressures. The community is actively debating the potential for a market correction or recession, with traders expressing sharp disagreement over whether the index's current technical levels indicate a breakout or a significant bearish reversal.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon Mobil is trending as investors react to rising crude prices and energy supply concerns linked to geopolitical tensions, particularly regarding shipping disruptions in the Strait of Hormuz. Community discussion is focused on the impact of these developments on potential earnings, with traders balancing bullish sentiment for energy majors against uncertainty regarding macro volatility and future production levels.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

The community is primarily focused on the potential valuation and upcoming S-1 filing for the Anthropic IPO, with many traders viewing the stock as an undervalued proxy for this event. Discussion often centers on discrepancies between current share price and net asset value (NAV), alongside speculation regarding management's recent insider share purchases and the timing of portfolio updates.

the cat on Base  community-run home for $BASECAT

Basecat

Traders are actively debating the price action of Basecat as it experiences significant volatility following a recent exchange listing, with many community members interpreting the current price dips as buying opportunities while others express skepticism over its long-term viability. The discourse is largely centered on potential reversal patterns and the speculative nature of meme coins, with participants monitoring market sentiment for the next leg of upward movement.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is trending as traders debate Cathie Wood's investment strategy, specifically highlighting her frequent rotation of holdings and the fund's long-term performance relative to the S&P 500. Community sentiment remains polarized, with many criticizing the fund's recent management decisions while others continue to view it as a concentrated bet on long-term disruptive innovation.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is trending as traders react to extreme volatility in South Korean equities, driven by significant margin call-related selling in the KOSPI and concerns over AI-sector capital expenditure. While some market participants are bargain hunting following the sharp decline, others remain cautious due to the structural risks inherent in the leveraged ETF's reliance on a highly concentrated and volatile index.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sellas Life Sciences (SLS) shares declined significantly amid community speculation regarding a third-party clinical trial survival model and concerns over a prolonged quiet period. While traders debated the potential for a trial failure versus a delayed event rate signaling therapeutic efficacy, institutional ownership levels remain a focal point of contention among investors.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS PR Newswire NEW YORK, Sept. 10, 2026 NEW YORK, Sept. 10...

Dow, S&P 500, Nasdaq Futures Edge Higher Ahead Of PPI, Jobless Claims: NVDA, AAPL, META, ORCL, TSM, TSLA, SLS In Focus 

Equity

Retail sentiment on Stocktwits turned cautious, dipping to ‘neutral’ on SPY and ‘bearish’ on QQQ.

SLS, IBRX In Focus: Canadian Insurance Giant Manulife’s Unit Raises Stakes Ahead Of Key Cancer Catalysts 

Its IBRX stake jumped 27.5% to 243,678 shares worth $2.13 million, bringing both positions’ combined value to $2.86 million.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS PR Newswire NEW YORK, Sept. 3, 2026 NEW YORK, Sept. 3, 2026...

Sellas Gears Up To Present Preclinical SLS009 Data For Pancreatic Cancer At Major Oncology Conference

Three abstracts evaluating SLS009 have been accepted for poster presentations at the AACR Conference on Pancreatic Cancer later in September.

Nasdaq, Dow, S&P 500 Futures Begin September On Weak Footing: Why NVDA, AAPL, TSLA, PANW, DELL, SLS, HUT Are In Focus

Retail sentiment on Stocktwits remained constructive despite rising geopolitical friction: ‘bullish’ on SPY and ‘neutral’ on QQQ.


SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’

Retail traders viewed the Merida acquisition as evidence that Big Pharma will pay rich premiums for immune-focused platforms.

Sellas CEO Stergiou Says ‘Rigorous, Unblinded’ Data From Pivotal AML Trial Will 'Speak For Itself' As REGAL Catalyst Nears

In a post on LinkedIn on Monday, Angelos Stergiou said despite speculation and outside commentary ‘naturally’ increasing, the company will let the data speak for itself.


Why Are Nasdaq, S&P 500 Futures Subdued Premarket? NVDA, AAPL, INTC, CRWD, RKLB, SLS Stocks In Focus

Retail sentiment on Stocktwits remained constructive despite rising geopolitical friction: ‘bullish’ on SPY and ‘neutral’ on QQQ.



Frank Gerola's BMF Targets SELLAS Life Sciences $3 Billion Valuation: Biotech's 'Most Expensive Coin Flip'

Short seller BMF Capital disclosed a short position in SELLAS Life Sciences, arguing the market has 'dangerously overvalued' the biotech.read more...

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Bearish Sentiment

$TMDX

$SLS

Which of these trending stocks are you most tempted to buy - $ON, $TMDX, $SLS, or $BE?

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLS News